BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis

NCT00001789 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Glomerulonephritis, Membranoproliferative
Lupus Nephritis

Interventions

DRUG: BG9588

Sponsor

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)